Similarly, MSCs derived from the human umbilical cord ameliorate experimental non-alcoholic steatohepatitis (NASH) in mice by targeting the nuclear factor erythroid 2-related factor (NRF) 2 pathway [108]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.